The SMC’s mission is to improve the public understanding of science by ensuring that the news media has easy access to the very best experts and evidence when science hits the headlines.
It has been announced that the one-dose Janssen COVID-19 vaccine has today been given regulatory approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
A press release from Moderna announces the TeenCOVE study of its COVID-19 vaccine in adolescents meets primary endpoint and plans to submit data to regulators in early June.
A letter published in the Journal of Neurology Neurosurgery & Psychiatry discusses three cases of ischaemic stroke, blood clots in arteries causing lack of blood supply to part of the brain, reported in young adults after receiving the Oxford–AstraZeneca vaccine.
A preprint from Public Health England (PHE) looks at the effectiveness of COVID-19 vaccines against the B.1.617.2 variant first identified in India.
An expert reaction to a preprint looking at the immune response in older people after vaccination the Pfizer COVID-19 vaccine with either a 3-week or a 12-week dosing schedule, as posted on MedRxiv
A study published in The BMJ looks at the public health impact of delaying the second dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine.
It has been announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to include adolescents from 12 to 15 years old.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the Oxford-AstraZeneca COVID-19 vaccine for people under the age of 40.
Two preprints, unpublished non-peer reviewed studies, by Public Health England (PHE), look at the effectiveness of the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines in protecting against death and hospitalisation from COVID-19.
The U.S. Trade Representative Katherine Tai released a statement today announcing the Biden-Harris Administration’s support for waiving intellectual property (IP) protections for COVID-19 vaccines.
A paper published in the New England Journal of Medicine (NEJM) looks at results from the phase 2a-b trial of Novavax COVID-19 vaccine in South Africa.
A study published in the BMJ looks at arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with the Oxford-AstraZeneca COVID-19 vaccine in Denmark and Norway.
A observational study published in the Lancet looks at impact and effectiveness of the Pfizer-BioNTech COVID-19 vaccine against infections, cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel.
The UK Science Media Centre has its roots in the influential House of Lords Science and Technology Select Committee third report on Science and Society, which sought to renew public trust in science after media frenzies on GM Crops and MMR. Established in 2002, it is an independent press office with a database of 3000 top quality scientists prepared to engage with journalists.
The Centre proactively makes the best scientists available to:
-Answer journalists questions on topical controversies
-Comment on breaking news and challenge misleading claims
- Assess new scientific findings, highlighting caveats and limitations
-Publicise new science in a measured and accurate way
The SMC’s philosophy is:
“The media will DO science better when scientists DO the media better.”
The UK Science Media Centre has its roots in the influential House of Lords Science and Technology Select Committee third report on Science and Society, which sought to renew public trust in science after media frenzies on GM Crops and MMR. Established in 2002, it is an independent press office with a database of 3000 top quality scientists prepared to engage with journalists.
The Centre proactively makes the best scientists available to:
-Answer journalists questions on topical controversies
-Comment on breaking news and challenge misleading claims
- Assess new scientific findings, highlighting caveats and limitations
-Publicise new science in a measured and accurate way
The SMC’s philosophy is:
“The media will DO science better when scientists DO the media better.”
